R&D in Drug Development: Addressing Opioids and Affordable Drugs
R&D and Drug Development: The Need for Affordable Drugs
The ongoing crisis of opioids and the emergence of antibiotic-resistant infections highlight the urgency behind R&D in drug development. Big pharma plays a pivotal role in this landscape, yet constraints on drug patents can stymie innovation and access to essential medications.
Reforming Drug Patents Under the IRA
Implementing effective reforms to drug patents as proposed in the Inflation Reduction Act (IRA) is vital for creating affordable drugs. This shift could ensure that future treatments are available, especially for diseases requiring small molecules and innovative therapies.
- Focus on R&D
- Aim for affordable drugs
- Address opioid crisis
- Combat antibiotic resistance
- Revise drug patent regulations
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.